tradingkey.logo
tradingkey.logo
Buscar

Co-Diagnostics Inc

CODX
Añadir a la lista de seguimiento
1.630USD
+0.030+1.88%
Cierre 05/14, 16:00ETCotizaciones retrasadas 15 min
113.83KCap. mercado
PérdidaP/E TTM

Más Datos de Co-Diagnostics Inc Compañía

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Información de Co-Diagnostics Inc

Símbolo de cotizaciónCODX
Nombre de la empresaCo-Diagnostics Inc
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoEgan (Dwight H)
Número de empleados132
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 12
Dirección2401 S. Foothill Dr. Suite D
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84109
Teléfono18014381036
Sitio Webhttps://codiagnostics.com/
Símbolo de cotizaciónCODX
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoEgan (Dwight H)

Ejecutivos de Co-Diagnostics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.75K
-2.06%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.75K
-2.06%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.67K
-2.07%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.67K
-2.07%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.75K
-2.06%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
10.75K
-2.06%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.67K
-2.07%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
10.67K
-2.07%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
581.55K
93.42%
Rest of the world
40.94K
6.58%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: hace 23 horas
Actualizado: hace 23 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Orca Capital GmbH
1.74%
Private Advisory Group LLC
1.15%
Egan (Dwight H.)
0.82%
Renaissance Technologies LLC
0.68%
Abbott (Richard David)
0.66%
Otro
94.95%
Accionistas
Accionistas
Proporción
Orca Capital GmbH
1.74%
Private Advisory Group LLC
1.15%
Egan (Dwight H.)
0.82%
Renaissance Technologies LLC
0.68%
Abbott (Richard David)
0.66%
Otro
94.95%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
3.59%
Individual Investor
3.39%
Hedge Fund
0.72%
Investment Advisor/Hedge Fund
0.56%
Research Firm
0.24%
Bank and Trust
0.02%
Otro
91.49%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
75
248.15K
6.89%
-158.74K
2025Q4
80
11.14M
13.43%
-308.03K
2025Q3
83
11.45M
12.86%
+6.26M
2025Q2
88
5.18M
18.12%
-695.54K
2025Q1
96
5.88M
20.77%
-1.09M
2024Q4
104
5.75M
18.48%
+1.31M
2024Q3
108
4.45M
20.26%
-229.17K
2024Q2
125
4.65M
21.94%
+232.83K
2024Q1
134
4.41M
23.86%
-3.05M
2023Q4
144
4.75M
24.82%
-54.54K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Orca Capital GmbH
62.86K
3.1%
-10.27K
-14.04%
Oct 28, 2025
Private Advisory Group LLC
39.39K
1.94%
--
--
Dec 31, 2025
Egan (Dwight H.)
28.73K
1.42%
+3.79K
+15.21%
Nov 23, 2025
Renaissance Technologies LLC
24.34K
1.2%
-4.57K
-15.81%
Dec 31, 2025
Abbott (Richard David)
23.22K
1.14%
+1.32K
+6.01%
Nov 23, 2025
Brown (Brian Lee)
23.09K
1.14%
+3.12K
+15.59%
Nov 23, 2025
Geode Capital Management, L.L.C.
14.97K
0.74%
+4.31K
+40.37%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
14.25K
0.7%
--
--
Dec 31, 2025
Murphy (Ted)
9.39K
0.46%
+722.00
+8.33%
Oct 31, 2025
Serbin (Richard S)
10.97K
0.54%
+1.92K
+21.17%
Nov 23, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Jul 11, 2025
Merger
30→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Jul 11, 2025
Merger
30→1
KeyAI